BioSpace News Archive

Sutro Biopharma, Inc. announced that the company will present at the 38th Annual J.P. Morgan Healthcare Conference on Thursday, Jan. 16, 2020, at 9:00 AM PST at the Westin St. Francis in San Francisco.

Ionis Pharmaceuticals, Inc., the leader in RNA-targeted therapeutics, announced the appointment of Onaiza Cadoret-Manier as chief corporate development and commercial officer reporting to Brett P. Monia, Ph.D., chief executive officer.

Infinity Pharmaceuticals, Inc. announced that Adelene Perkins, Chief Executive Officer and Chair of Infinity Pharmaceuticals, will provide a corporate overview at the 38th Annual J.P. Morgan Global Healthcare Conference on Thursday, January 16, 2020 at 9:00 am Pacific Time at the Westin St. Francis Hotel in San Francisco, California.

Three programs with clinical trial results in 2020 including OTIVIDEX™ Phase 3 trial in Ménière’s disease

On track to submit IND application for lead candidate, NTLA-2001 for transthyretin amyloidosis, in mid-2020 and dose first patients in 2H 2020

Encompass Health Corp. announced it will report results for its fourth quarter ended Dec. 31, 2019, after the market closes on Feb. 6, 2020. The Company will host an investor conference call at 9 a.m. ET on Feb. 7, 2020, to discuss its results..

IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”) a leader in pharmaceutical films, today announced that it has entered into a Feasibility Study Agreement (the “Agreement”) with an undisclosed partner (the “Partner”) focused on bringing innovative animal health products to the market.

Kintai Therapeutics, a Flagship Pioneering company, today announced the appointment of biotech industry veteran John Mendlein, Ph.D., to its Board of Directors as chairman of the board

Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases, today announced an expansion of its Bruton tyrosine kinase (BTK) franchise with PRN473 Topical.

Eli Lilly and Company (NYSE: LLY) and Strateos, Inc. today unveiled a new robotic laboratory in San Diego, California designed to accelerate the drug discovery process.